Search research articles
Contact Us
Filters
Showing results (1-10 of 131) with videos related to
Page
of 14
Sort By:
Rheumatology (Oxford, England)
|
August 4, 2023
ANCA positivity and the limited expression of vasculitides
Philippe Guilpain
Rheumatology (Oxford, England)
|
October 11, 2022
JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use
Philippe Guilpain
Clinical Reviews in Allergy & Immunology
|
January 30, 2008
Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases
Philippe Guilpain, Luc Mouthon
Rheumatology (Oxford, England)
|
January 5, 2022
Cancer-associated systemic sclerosis in a Canadian cohort: beyond strengths and weaknesses of epidemiological studies
Philippe Guilpain, Caroline Mollevi
BMC Medicine
|
January 7, 2017
About the complexity of adult onset Still's disease… and advances still required for its management
Philippe Guilpain, Alain Le Quellec
Presse Medicale (Paris, France : 1983)
|
February 25, 2012
[Anti-inflammatory and immunosuppressive properties of corticosteroids]
Philippe Guilpain, Claire Le Jeunne
Presse Medicale (Paris, France : 1983)
|
April 6, 2007
[Classification of systemic vasculatides]
Loïc Guillevin, Christian Pagnoux, Philippe Guilpain
Presse Medicale (Paris, France : 1983)
|
March 14, 2007
[New insights into the pathogenesis of ANCA-positive vasculitides]
Philippe Guilpain, Loïc Guillevin, Luc Mouthon
Presse Medicale (Paris, France : 1983)
|
March 14, 2007
[Microscopic polyangiitis]
Christian Pagnoux, Philippe Guilpain, Loïc Guillevin
Frontiers in Immunology
|
October 18, 2021
Editorial: Key Players in Systemic Sclerosis: The Immune System and Beyond
Philippe Guilpain, Danièle Noël, Jérôme Avouac
Page
of 14
Search research articles
Search
Showing results (1-10 of 131) with videos related to
Sort By:
Page
of 14
Rheumatology (Oxford, England)
|
August 4, 2023
ANCA positivity and the limited expression of vasculitides
Philippe Guilpain
Rheumatology (Oxford, England)
|
October 11, 2022
JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use
Philippe Guilpain
Clinical Reviews in Allergy & Immunology
|
January 30, 2008
Antiendothelial cells autoantibodies in vasculitis-associated systemic diseases
Philippe Guilpain, Luc Mouthon
Rheumatology (Oxford, England)
|
January 5, 2022
Cancer-associated systemic sclerosis in a Canadian cohort: beyond strengths and weaknesses of epidemiological studies
Philippe Guilpain, Caroline Mollevi
BMC Medicine
|
January 7, 2017
About the complexity of adult onset Still's disease… and advances still required for its management
Philippe Guilpain, Alain Le Quellec
Presse Medicale (Paris, France : 1983)
|
February 25, 2012
[Anti-inflammatory and immunosuppressive properties of corticosteroids]
Philippe Guilpain, Claire Le Jeunne
Presse Medicale (Paris, France : 1983)
|
April 6, 2007
[Classification of systemic vasculatides]
Loïc Guillevin, Christian Pagnoux, Philippe Guilpain
Presse Medicale (Paris, France : 1983)
|
March 14, 2007
[New insights into the pathogenesis of ANCA-positive vasculitides]
Philippe Guilpain, Loïc Guillevin, Luc Mouthon
Presse Medicale (Paris, France : 1983)
|
March 14, 2007
[Microscopic polyangiitis]
Christian Pagnoux, Philippe Guilpain, Loïc Guillevin
Frontiers in Immunology
|
October 18, 2021
Editorial: Key Players in Systemic Sclerosis: The Immune System and Beyond
Philippe Guilpain, Danièle Noël, Jérôme Avouac
Page
of 14